CDMRP New Cancer Related Funding

Aug 17, 2020, 16:18 PM by Melodi Moore
cdmrp_logo

FY20 Rare Cancers Research Program

Concept Award
Pre-Application Due:  November 12, 2020
Application Due:    November 30, 2020

Supports highly innovative, untested, potentially groundbreaking novel concepts in rare cancers. The Concept Award is not intended to support
an incremental progression of an already established research project; instead, it allows Principal Investigators (PIs) the opportunity to pursue serendipitous observations. Preliminary data are not required. This award mechanism supports high-risk studies that have the potential to reveal
entirely new avenues for investigation. Applications must describe how the new idea will enhance the existing knowledge of rare cancers or develop an innovative and novel course of investigation. Research completed through a Concept Award may generate sufficient preliminary data to enable the PI to prepare an application for future research.

Idea Development Award
Pre-Application Due:  November 12, 2020
Application Due:    November 30, 2020

Promotes new ideas that are still in the early stages of development and have the potential to yield impactful data and new avenues of investigation. This award supports conceptually innovative, high-risk/high-reward research that could lead to critical discoveries or major advancements that will accelerate progress toward eradicating deaths and suffering from rare cancers. Applications should include a well formulated, testable hypothesis based on strong scientific rationale.

Preliminary data with disease-specific rationale (including correlatives in existing trials) to support the feasibility of the research hypotheses and research approaches are required; however, these data do not necessarily need to be derived from studies of the proposed rare cancer type(s)/sub-type(s) under study.

Resource and Community Development Award
Pre-Application Due:  November 12, 2020
Application Due:    November 30, 2020

Supports the development of resources to advance the field of rare cancers research and ultimately improve outcomes for individuals with rare cancers. Major gaps in patient care of rare cancers include lack of communication and dissemination strategies for rare cancer research and clinical findings within communities; lack of therapeutics and mechanistic studies to inform treatment development; lack of research and clinical resources including patient tissues, cell, and tumor models; and lack of infrastructure for sharing data and other resources. 



FY20 Kidney Cancer Research Program

Clinical Research Nurse Development Award
Pre-Application Due:  October 13, 2020
Application Due:    November 3, 2020

The inclusion of clinical trial research nurses on a multi-disciplinary clinical research team is thought to be a valuable asset in executing the day-to-day management of a clinical trial. Clinical research nurses (CRNs) perform an essential role to ensure that the integrity and quality of clinical trials are maintained while also safeguarding the welfare of clinical research and/or
trial participants.